wl 19 has been researched along with Neuralgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muralidharan, A; Smith, MT; Walther, T; Woodruff, TM; Wyse, BD | 1 |
| Lau, T; Rice, AS; Smith, MT; Wallace, VC; Wyse, BD | 1 |
2 other study(ies) available for wl 19 and Neuralgia
| Article | Year |
|---|---|
A small molecule angiotensin II type 2 receptor (ATâ‚‚R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia.
Topics: Analgesics; Angiotensin II Type 2 Receptor Blockers; Animals; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Female; Ganglia, Spinal; Imidazoles; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Sequence Data; Neuralgia; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley | 2013 |
Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy.
Topics: Analgesics; Angiotensin II Type 2 Receptor Blockers; Animals; Anti-HIV Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Hot Temperature; Hyperalgesia; Imidazoles; Male; Neuralgia; Polyneuropathies; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sciatic Neuropathy; Time Factors; Touch; Zalcitabine | 2014 |